KCTD9

Chr 8

potassium channel tetramerization domain containing 9

Also known as: BTBD27

Enables cullin family protein binding activity and identical protein binding activity. Predicted to be involved in intracellular signal transduction; protein homooligomerization; and protein ubiquitination. Predicted to act upstream of or within several processes, including NK T cell lineage commitment; natural killer cell activation; and response to virus. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
5
Pubs (1 yr)
P/LP submissions
P/LP missense
0.52
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.52LOEUF
pLI 0.062
Z-score 3.35
OE 0.28 (0.160.52)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.60Z-score
OE missense 0.30 (0.240.37)
62 obs / 208.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.28 (0.160.52)
00.351.4
Missense OE?0.30 (0.240.37)
00.61.4
Synonymous OE?0.91
01.21.6
LoF obs/exp: 7 / 25.1Missense obs/exp: 62 / 208.5Syn Z: 0.60

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

KCTD9 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →